We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Alimera Sciences Inc | NASDAQ:ALIM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.18 | 5.44% | 3.49 | 3.33 | 4.30 | 3.50 | 3.28 | 3.28 | 17,332 | 01:00:00 |
Delaware
|
|
001-34703
|
|
20-0028718
|
||
(State or other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
||
|
|
|
||||
6120 Windward Parkway
Suite 290
Alpharetta, Georgia
|
|
30005
|
||||
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Not Applicable
|
(Former name or former address if changed since last report.)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.01 par value per share
|
ALIM
|
The Nasdaq Stock Market LLC
(Nasdaq Global Market)
|
Proposal 1:
|
The election of two directors to serve as Class III directors for a term of three years until the 2022 annual meeting of stockholders.
|
|
|
Proposal 2:
|
The ratification of the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019.
|
|
|
Proposal 3:
|
The approval, on an advisory basis, of the compensation of the Company’s named executive officers.
|
|
|
Proposal 4:
|
The approval of the 2019 Plan.
|
Proposal 1:
|
Election of Directors.
|
Directors
|
Votes For
|
Votes Withheld
|
Broker Non-Votes
|
Brian K. Halak, Ph.D.
|
39,833,294
|
238,234
|
16,303,314
|
Peter J. Pizzo, III
|
39,833,294
|
238,234
|
16,303,314
|
Proposal 2:
|
Ratification of appointment of Grant Thornton LLP.
|
Votes For
|
Votes Against
|
Votes Abstaining
|
Broker Non-Votes
|
54,909,024
|
1,355,321
|
110,497
|
0
|
Proposal 3:
|
Approval of Compensation of Named Executive Officers.
|
Votes For
|
Votes Against
|
Votes Abstaining
|
Broker Non-Votes
|
39,413,989
|
552,579
|
104,960
|
16,303,314
|
Proposal 4:
|
Approval of the 2019 Plan.
|
Votes For
|
Votes Against
|
Votes Abstaining
|
Broker Non-Votes
|
37,540,186
|
2,457,516
|
73,826
|
16,303,314
|
Exhibit
No.
|
|
Description
|
10.60
|
|
|
10.61
|
|
|
ALIMERA SCIENCES, INC.
|
|
|
|
|
Dated: June 19, 2019
|
By:
|
/s/ J. Philip Jones
|
|
Name:
|
J. Philip Jones
|
|
Title:
|
Chief Financial Officer
|
1 Year Alimera Sciences Chart |
1 Month Alimera Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions